Purchase Order 75N98026P00308
- Not listed
- The National Cancer Institute awarded a firm fixed-price purchase order to Leica Microsystems Inc. (Leica Biosystems division) for a maintenance service agreement valued at $60,663.20, with performance in Bethesda, Maryland and completion by February 28, 2027. This non-set-aside contract, awarded March 1, 2026, represents a continuation of the agency's relationship with Leica, a specialized manufacturer of microscopy systems and laboratory instrumentation that serves critical roles in federal...
- The U.S. National Cancer Institute has awarded a $21,025.20 firm-fixed-price purchase order contract to Leica Microsystems Inc., a manufacturer of microscopes, scientific instruments, and imaging equipment, to provide service for a Leica Bond instrument. The contract has an ultimate completion date of December 14, 2025. Leica Microsystems Inc. is a for-profit organization that operates through its Leica Biosystems division, and has been awarded numerous federal contracts by agencies such as...
- The National Cancer Institute awarded a $202,490.42 firm fixed price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on June 13, 2024, for preventive maintenance services on one Leica Stellaris microscope under a Premium Care service agreement. The contract extends through June 12, 2029, and will be performed at Leica's facility in Riverwoods, Illinois. No small business set-aside designation was used in this competitive award to the original equipment manufacturer,...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a one-year, firm fixed price purchase order valued at approximately $15,758 to Leica Microsystems Inc.'s Leica Biosystems Division. The contract is for maintenance services to support the agency's cancer research efforts. As the prime contractor, Leica Biosystems will perform the requested maintenance work at its facility located in Riverwoods, Illinois. No subcontractors or set aside...
- The National Cancer Institute (NCI), an agency within the National Institutes of Health, awarded a $545,992.04 firm fixed-price purchase order to Leica Microsystems Inc. (Leica Biosystems division) on March 27, 2025, for preventative maintenance and emergency repair services for three government-owned Leica imaging devices supporting cancer research at the Center for Cancer Research in Bethesda, Maryland. The devices include a Leica Stellaris 5 confocal microscope, a Leica CellDIVE microscope,...
- The National Cancer Institute awarded a firm fixed-price purchase order valued at $402,725 to Leica Microsystems Inc. (through its Leica Biosystems division) for maintenance services on specialized confocal microscopy equipment supporting the Thoracic and GI Malignancies Branch. The contract covers preventative maintenance, on-site emergency repairs, software support, and parts replacement for two government-owned instruments: a Leica Basic Module TCS SP8 LIAchroic IR microscope and a Leica...
- Leica Microsystems Inc., through its Leica Biosystems division, was awarded a $4,355 firm fixed-price Blanket Purchase Agreement (BPA) call by the National Cancer Institute on April 9, 2014, with an ultimate completion date of March 31, 2015. This contract, issued without set-aside designation, represents a task order against an existing BPA vehicle and was performed at the National Cancer Institute's facility in Bethesda, Maryland. Leica Microsystems, a subsidiary of Danaher Corporation, is a...
- The Department of Health and Human Services' National Institutes of Health National Cancer Institute awarded a $17,470.20 firm fixed price purchase order to Leica Microsystems Inc.'s Leica Biosystems Division for a service agreement. The place of performance will be in Bethesda, Maryland. The one-year contract begins on December 1, 2023 and concludes on November 30, 2024. As the prime contractor, Leica Microsystems will provide unspecified services to support the National Cancer Institute's...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $29,369.56 delivery order contract to Leica Microsystems Inc.'s Leica Biosystems Division. The contract calls for the delivery of equipment to the prime contractor's facility in Riverwoods, Illinois under a firm fixed price arrangement. It was awarded against the contractor's Multiple Award Schedule contract vehicle and will provide the requested products and services from July 5, 2023...
- This is a firm fixed price Purchase Order contract awarded by the National Cancer Institute, a civilian agency, to Leica Microsystems Inc. for a maintenance agreement on a Leica Bond RXM Processing Module valued at $21,340.56. The equipment is utilized by the Hernandez Lab and Surgery Branch for ex vivo experiments and pathologist analysis. The contract has a completion date of May 10, 2026 and does not have a set-aside designation. Leica Microsystems Inc. is a manufacturer of microscopes,...
The National Cancer Institute awarded a $125,135.79 firm fixed-price purchase order to Leica Microsystems Inc.'s Leica Biosystems division for a service agreement covering the Leica BOND RXM, an automated immunohistochemistry staining system widely used in cancer research and diagnostic pathology. The contract, awarded on May 11, 2026, with an ultimate completion date of May 10, 2031, will be performed at Leica's facility in Riverwoods, Illinois. This award was made on an unrestricted, open basis with no set-aside designation, reflecting competitive procurement practices. The service agreement typically includes preventative maintenance, on-site repairs, replacement parts, and technical support to ensure operational continuity of the BOND RXM platform at NCI facilities. Leica Microsystems has established itself as a critical vendor to the federal government through extensive prime contract awards and indefinite delivery vehicles across multiple agencies, including the National Institutes of Health, Department of Veterans Affairs, Food and Drug Administration, and Department of Defense. The company's federal contracting history demonstrates substantial capacity in delivering specialized laboratory instrumentation, microscopy equipment, and comprehensive maintenance services to support biomedical research and diagnostic operations. This particular NCI service agreement aligns with the Institute's mission to support cancer research infrastructure and represents a continuation of Leica's role as a preferred provider of advanced pathology equipment and related services to the federal research community.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 4/15/26 |